Innate Pharma Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LION POINT CAPITAL, LP | 08/14/2026 | 81.15 K | $149.32 K | 0.00% | 0.09% |
| MORGAN STANLEY | 08/13/2026 | 43.52 K | $80.08 K | 0.00% | 0.05% |
| SMARTHARVEST PORTFOLIOS, LLC | 08/04/2026 | 23.75 K | $43.70 K | 100.00% | 0.03% |
| XTX TOPCO LTD | 08/14/2026 | 15.13 K | $27.84 K | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 09/02/2026 | 12.44 K | $22.89 K | 100.00% | 0.01% |
| JANE STREET GROUP, LLC | 08/14/2026 | 10.31 K | $18.97 K | -76.23% | 0.01% |
| RHUMBLINE ADVISERS | 08/12/2026 | 4.72 K | $8.68 K | -0.32% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 1.36 K | $2.51 K | 58.30% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 07/17/2026 | 21 | $38 | 110.00% | 0.00% |
| GAMMA INVESTING LLC | 07/07/2026 | 9 | $17 | -96.25% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Innate Pharma institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Innate Pharma. The most heavily invested institutionals were:
SmartHarvest Portfolios, LLC: 20,868
Caitong International Asset Management Co., Ltd: 74
Lion Point Capital, LP: 81,151
MORGAN STANLEY: 43,524
XTX Topco Ltd: 15,130
CITADEL ADVISORS LLC: 12,441
0.22% of Innate Pharma stock is owned by institutional investors.
Institutional investors have bought a total of 189.60 K shares in the last 24 months. This purchase volume represents approximately $276.81 K in transactions.